Industrial Purity Specifications for (S)-N-Glycidylphthalimide
- Critical Chiral Intermediate: Essential for the asymmetric synthesis of anticoagulants like Rivaroxaban, requiring strict enantiomeric excess control.
- Quality Metrics: Industrial-grade material must exceed 98% assay with minimal regioisomer impurities to ensure downstream reaction yields.
- Supply Chain Security: Reliable global manufacturers provide comprehensive COA documentation and scalable manufacturing processes for bulk orders.
In the landscape of modern pharmaceutical intermediates, few compounds demand as much scrutiny regarding stereochemistry and chemical stability as (S)-N-Glycidylphthalimide. Identified by CAS 161596-47-0, this chiral building block is pivotal in the production of next-generation anticoagulants and specialty polymers. For process chemists and procurement officers, understanding the nuance between research-grade samples and true industrial purity specifications is critical for maintaining batch consistency and regulatory compliance.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. recognizes that the efficacy of the final drug substance relies heavily on the quality of the starting chiral intermediate. This technical overview delineates the essential purity parameters, analytical methods, and documentation standards required for successful bulk procurement.
Defining Industrial vs. Pharmaceutical Grade Purity
While laboratory suppliers often list purity levels around 95% to 98% for small-scale research, industrial applications necessitate tighter controls. The industrial purity standard for (S)-N-Glycidylphthalimide typically requires an assay of greater than 98.5% via HPLC, with specific limits on known impurities. The presence of the (R)-enantiomer must be strictly controlled, as even minor deviations in enantiomeric excess (ee%) can compromise the biological activity of the final pharmaceutical product.
Furthermore, the stability of the epoxide ring is a primary concern during storage and transport. Industrial specifications must account for hydrolysis products, such as the corresponding diol, which can form if moisture control is inadequate during the manufacturing process. High-quality bulk supply ensures that the material is packaged under inert atmosphere conditions to prevent ring-opening reactions prior to use in the synthesis reactor.
Key Analytical Metrics: Assay, ee%, and Impurity Profiles
To validate the quality of 2-[(2S)-Oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione, a multi-method analytical approach is required. Relying solely on a single technique is insufficient for GMP-grade procurement. The following metrics define the quality baseline:
- Chemical Assay (HPLC): Quantifies the main peak area relative to total impurities. Industrial batches should demonstrate >98.5% area normalization.
- Chiral Purity (Chiral HPLC/GC): Determines the enantiomeric excess. For this intermediate, an ee% of >99.0% is often required to meet downstream synthesis targets.
- Residual Solvents (GC-Headspace): Compliance with ICH Q3C guidelines is mandatory. Common solvents like dichloromethane or toluene used during crystallization must be below permitted daily exposure limits.
- Heavy Metals (ICP-MS): Ensures catalyst residues from the synthesis route are reduced to ppm levels acceptable for pharmaceutical use.
The molecular formula C11H9NO3 and molecular weight of 203.19 g/mol provide the baseline for mass spectrometry confirmation. Additionally, the melting point range of 100°C to 104°C serves as a quick physical identity test, though it is less specific than spectroscopic methods. NMR spectroscopy is utilized to confirm the structural integrity of the isoindoline-1,3-dione core and the substitution pattern on the nitrogen atom.
COA Requirements for GMP-Compliant Procurement
When sourcing materials for clinical or commercial production, the Certificate of Analysis (COA) is the definitive document verifying quality. A robust COA for (S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione should not only list the batch number and manufacturing date but also provide actual test results rather than simple pass/fail indicators. This transparency allows quality assurance teams to track trends in impurity profiles over time.
Procurement strategies should prioritize suppliers who can demonstrate consistent batch-to-b reproducibility. For example, when sourcing high-purity (S)-(+)-Glycidyl Phthalimide, buyers should verify that the supplier maintains stability data proving the material retains its specifications over a defined shelf life under recommended storage conditions. This is particularly important for epoxide-containing compounds which are susceptible to degradation.
Technical Specifications Overview
The table below outlines the typical technical parameters expected for industrial-grade procurement.
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | White to Off-White Crystalline Powder | Visual |
| Assay (Purity) | > 98.5% | HPLC |
| Enantiomeric Excess (ee%) | > 99.0% | Chiral HPLC |
| Melting Point | 100°C – 104°C | DSC / Capillary |
| Loss on Drying | < 0.5% | Karl Fischer / LOD |
| Residual Solvents | Compliant with ICH Q3C | GC-Headspace |
Commercial Considerations and Bulk Supply
Beyond technical specifications, the commercial viability of a supply partner is determined by their ability to scale. The bulk price of chiral intermediates is influenced by the complexity of the resolution or asymmetric synthesis required to achieve the desired stereochemistry. Suppliers capable of multi-ton production can offer more stable pricing structures compared to those limited to kilogram-scale laboratory synthesis.
Logistics and regulatory documentation are equally vital. International shipments require proper classification under UNSPSC Code 12352210 and adherence to hazardous material regulations, given the irritant properties (H315, H319) associated with the compound. A reliable partner ensures that Safety Data Sheets (SDS) and Certificates of Origin (COO) are readily available to facilitate customs clearance and environmental health and safety compliance.
In conclusion, securing a supply of (S)-N-Glycidylphthalimide requires a partnership grounded in technical excellence and transparency. NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support global pharmaceutical clients with high-specification intermediates that meet rigorous industrial standards. By prioritizing verified analytical data and robust manufacturing capabilities, manufacturers can mitigate supply chain risks and ensure the successful development of life-saving therapeutics.